Full Text View
Tabular View
No Study Results Posted
Related Studies
Bone Marrow Transplant From Related Donor for Patients With High Risk Hemoglobinopathies
This study has been terminated.
Study NCT00040469   Information provided by Baylor College of Medicine
First Received: June 26, 2002   Last Updated: April 9, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sickle Cell Anemia
Hemoglobinopathy
Thalassemia
Additional conditions recognized in this trial
Anemia, Sickle Cell
Hemoglobinopathies
More general conditions related to this trial
Anemia
Anemia, Hemolytic
Anemia, Hemolytic, Congenital
Genetic Diseases, Inborn
Hematologic Diseases
Interventions listed in this trial
Campath -1H
Dilantin
Busulfan
Cyclophosphamide
Additional drug interventions recognized in this trial
Alemtuzumab
More general drug interventions related to this trial
Alkylating Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antirheumatic Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Baylor College of Medicine
The Methodist Hospital System
Texas Children's Hospital
Center for Cell and Gene Therapy


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services